Evidence map›Paper›PMID 21878527›Full record

ArticleLearning & memory (Cold Spring Harbor, N.Y.)2011

Xamoterol impairs hippocampus-dependent emotional memory retrieval via Gi/o-coupled β2-adrenergic signaling.

Keith Schutsky, Ming Ouyang, Steven A Thomas

Open access · diamondAbstract read
In one paragraph

Article in Learning & memory (Cold Spring Harbor, N.Y.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. AlphaFrontiers in behavioral neuroscience · 2022
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Noradrenergic Modulation of Fear Conditioning and Extinction.Frontiers in behavioral neuroscience · 2018
    Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Noradrenergic dysfunction in Alzheimer's disease.Frontiers in neuroscience · 2015
    Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Stress and glucocorticoids impair memory retrieval via β2-adrenergic, Gi/o-coupled suppression of cAMP signaling.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Keith SchutskyDepartment of Pharmacology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Ming Ouyang
Steven A Thomas
University of Pennsylvania · US

Funding

PREDOCTORAL TRAINING PROGRAM IN PHARMACOLOGYT32GM008076 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI BLENDY, JULIE A · 1985 to 2023
$10.8M
Molecular mechanisms of memrory retrievalR01MH063352 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI THOMAS, STEVEN A · 2002 to 2011
$3.2M
NIGMS NIH HHS 5T32GM008076NIGMS NIH HHS T32 GM008076NIMH NIH HHS 5R01MH063352NIMH NIH HHS R01 MH063352
6 · The paper itself

Abstract

Xamoterol, a partial β(1)-adrenergic receptor agonist, has been reported to impair the retrieval of hippocampus-dependent spatial reference memory in rats. In contrast, xamoterol restores memory retrieval in gene-targeted mice lacking norepinephrine (NE) and in a transgenic mouse model of Down syndrome in which NE levels are reduced. Restoration of retrieval by xamoterol in these two models complements the observation that NE and β(1) signaling are required for hippocampus-dependent retrieval of contextual and spatial reference memory in wild-type mice and rats. Additional evidence indicates that cAMP-mediated PKA and Epac signaling are required for the retrieval of hippocampus-dependent memory. As a result, we hypothesized that xamoterol has effects in addition to the stimulation of β(1) receptors that, at higher doses, act to counter the effects of β(1) signaling. Here we report that xamoterol-induced disruption of memory retrieval depends on β(2)-adrenergic receptor signaling. Interestingly, the impairment of memory retrieval by xamoterol is blocked by pretreatment with pertussis toxin, an uncoupling agent for G(i/o) signaling, suggesting that β(2) signaling opposes β(1) signaling during memory retrieval at the level of G protein and cAMP signaling. Finally, similar to the time-dependent roles for NE, β(1), and cAMP signaling in hippocampus-dependent memory retrieval, xamoterol only impairs retrieval for several days after training, indicating that its effects are also limited by the age of the memory. We conclude that the disruption of memory retrieval by xamoterol is mediated by G(i/o)-coupled β(2) signaling, which opposes the G(s)-coupled β(1) signaling that is transiently required for hippocampus-dependent emotional memory retrieval.

Indexed as

Adrenergic beta-1 Receptor AgonistsAdrenergic beta-AntagonistsAnalysis of VarianceAnimalsBehavior, AnimalChi-Square DistributionConditioning, ClassicalConditioning, OperantDose-Response Relationship, DrugEmotionsFearGTP-Binding Protein alpha Subunits, Gi-GoHippocampusMemory DisordersMental RecallMiceAdrenergic beta-1 Receptor AgonistsAdrenergic beta-AntagonistsGTP-Binding Protein alpha Subunits, Gi-GoICI 118551Pertussis ToxinPropanolaminesReceptors, Adrenergic, beta-1Receptors, Adrenergic, beta-2Xamoterol

Identifiers

PMID21878527
PMCPMC3166789
OpenAlexW2141547240

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.